The Sickness Industrial Complex

Written by Roman Bystrianyk on August 25, 2026. Posted in Current News

Modern life is making us sick, and the system that profits from our sickness has little incentive to change.

The dramatic rise in chronic disease since the 1960s is not a failure of medicine but a predictable consequence of how we live: we sit too much, eat processed food, suffer unrelenting stress, sleep poorly, and isolate ourselves from genuine human connection.

Meanwhile, the “Sickness Industrial Complex”—an interlocking web of big agriculture, big food, big pharma, and their financial, political, and advertising allies—profits handsomely from treating the symptoms of these lifestyle diseases while ignoring their root causes.

The numbers tell a stark story: obesity has tripled since the 1960s, from 13.4% to over 40% of U.S. adults. Generations born after 1970 face worsening mortality from heart disease and cancer—a reversal of decades of health progress. We spend nearly 18% of our GDP on health care, yet we are sicker than our parents were. This is not because medicine has failed; it is because we have outsourced health to a system designed to manage disease, not prevent it.

Drawing on Sam’s personal testimony, historical data on infectious disease decline, and the work of physicians like Seth Capehart, MD, this essay traces how we arrived at this moment and offers a way out. The solution is neither a new drug nor a complex protocol. It is, quite simply, to live like a human: move daily, eat real food, manage stress, sleep well, and connect with others. These are not extreme measures. They are the baseline we have strayed from.

I. The Commercial: A Promise in a Minute

While grinding through my workout at the gym, I happened to glance up at the sprawling wall of screens. I routinely tune out that familiar noise, regarding the screens as little more than propaganda engines, each broadcasting its own curated brand of manipulation. But today, one caught my eye. There it was: the unmistakable, formulaic blueprint of a pharmaceutical advertisement. This one: another semaglutide fad pill, Wegovy.

An upbeat tune filled the air as a cheerful chorus crooned the medication’s name, drilling it into every captive viewer’s subconscious. The commercial unfolded scene after scene of manufactured bliss.

Overweight individuals, beaming with unearned confidence, jogged effortlessly before cannonballing into a crystalline lake. Elderly obese bodies, softened by age and gravity, pedaled bicycles with the unbridled joy of children, their laughter echoing against a backdrop of golden sunlight.

Another frame featured a heavyset man, drenched in sweat and glee, triumphantly putting at a whimsical mini-golf course bathed in the sugary glow of Disneyland magic.

Not a single shadow fell across this curated paradise. No ailments, no negative effects, no hospital beds. It was just a curated trailer of happiness, carefully engineered to sell not a pill, but a promise. The subtext hums louder than the tune: Buy this, and you too can live this life.

II. The Floodgates Open: How We Got Here

This is the world the FDA ushered in with its fateful 1997 decision—a regulatory shift that cracked open the floodgates and unleashed a relentless tide of televised pharmaceutical seduction.^[3] The numbers tell the story of a deluge: direct-to-consumer prescription drug advertising ballooned from $1.3 billion (79,000 ads) in 1997 to a staggering $6 billion (4.6 million ads, including 663,000 television commercials) by 2016.^[4]

So, we are left drowning in a ceaseless torrent of mesmerizing promises. Each commercial a happy song assuring us that salvation lies in a little bottle, a little shot. Every flaw, every ache, every problem, every whisper of mortality can be erased, if only we ask our doctor. The focus is relentlessly, ruthlessly positive.

The risks?

Buried in a monotone voiceover that rushes through a litany of horrors —kidney problems, pancreas inflammation, severe stomach problems—reduced to background noise, a technical formality. No commercial dares show the faces of those who trusted the promise and paid with their health. No images of hospital gurneys, no grieving families, no shattered lives. Just happy, happy, happy—an unbroken parade of smiles designed to anesthetize our skepticism.

If we slow that rush to the speed of understanding, we see that the happy, happy, happy message grinds to a halt.

“Don’t take if you or your family have a history of MTC (medullary thyroid cancer) or MEN2 (multiple endocrine neoplasia syndrome type 2), or if you are allergic to it. Tell your provider if you plan to have surgery or a procedure, are breastfeeding, pregnant, or plan to be. Stop taking it and get medical help right away if you get a lump or swelling in your neck, severe stomach pain, or serious allergic reaction.

Serious side effects include pancreas inflammation and gallbladder or severe stomach problems. Wegovy may cause low blood sugar in people with diabetes, especially if you take medicines for it. Call your prescriber if you experience vision changes or heart racing at rest. Side effects like nausea, vomiting, and diarrhea can lead to dehydration, which may cause kidney problems.”

We, the public, along with a medical system too often complicit, have been conditioned to look away. We’ve been trained to believe these tragedies are statistical anomalies, rare misfortunes that happen to someone else. But the statistics are not abstractions; they are mothers, fathers, neighbors. The system has programmed us to ignore the fine print, to trust the melody, to believe—against all evidence—that the nightmare will never knock on our door.

III. Sam’s Story: When the Promise Turns Sour

And yet, for all the gloss and glee of that televised paradise, the truth has a way of surfacing, not in the sterile glow of a commercial break, but in the raw, unvarnished testimony of those who trusted the pitch and paid the price. Plucking just one lived experience from the vast silence the advertisers depend upon should give anyone, everyone, a reason to pause and reconsider.

The sickly, syrupy promise that happiness can be uncorked from a little bottle curdles into something far more bitter when confronted with the reality on the other side of the prescription pad. Consider Sam, whose Ozempic (another semaglutide medication) story unfolds not as a triumph, but as a quiet cautionary tale:

“My experience is not very documented, but I can tell what I think was happening. I feel like I lost muscle tone. I did lose weight, but it quickly returned along with added weight. I was so sick I had to go to bed for a couple of days each month after my injection, and even after that. Actually, my entire life was just nausea and sickness during the time I was trying it. It definitely was NOT living. At this point, I wish I had never tried it, but I was desperate to lose weight and felt like I should try.

The absolute best results I’ve had are with a more whole-foods diet, fiber and probiotics every time I eat, watching carbs but not too closely, moderate protein, and a ton of intermittent fasting that is changed up every day, meaning fasting times, eating times, etc., are different every day. And a prolonged fast thrown in every so often. That is the absolute best luck I’ve had, and my resting blood glucose is lower than it’s been in a long time. Even at that, my weight comes off slowly, but it keeps coming off. So, I feel like this is a healthy way to do it.”

Here, in Sam’s unadorned words, the glossy happiness trailer crashes against the jagged rocks of lived experience. This was not a statistical outlier to be dismissed, but a woman who was desperate, hopeful, and ultimately betrayed by a promise that glittered from afar but crumbled on contact.

She did not find her salvation in a shot; she found it instead in the slow, unglamorous labor of whole foods, fasting, and patience. It’s a path that offered no anthem, no golden sunlight, no cannonball into a crystalline lake, and most importantly, no profits for a system that needs to be continually fed. Just steady, unspectacular progress, earned one day at a time.

Her story challenges the pharmaceutical euphoria. A reminder that the cure, for so many, becomes its own quiet catastrophe, and that the happiness we are sold so relentlessly is too often a mirage. Something beautiful from a distance, but dissolving into bitter dust the moment we reach out to grasp it.

To be clear, these medications do help some people lose weight, but at what potential cost? Semaglutide also carries a Boxed Warning for the risk of thyroid C-cell tumors, the FDA’s most prominent warning.^[5]

Among people taking Ozempic, about 1 in 100 developed gallstones. And about 1 in 1,000 people developed gallbladder infections.^[6] Information leaflets for drugs such as Wegovy, Ozempic, and Mounjaro state that pancreatitis is an “uncommon” side effect, affecting about 1 in 100 patients.^[7] And what about the long-term effects we just don’t know about?

IV. The Bigger Picture: Spending More, Getting Sicker

But the problem is much bigger than a single advertisement, or just a single drug or class of drugs. Modern medicine. Pharmaceuticals. Tests. Procedures. Our society has been shaped for decades by the notion that industrial medicine solves health problems, accelerating over the last 50 years or so.

In 1930, Americans spent $2.8 billion on health care—$23 per person and 3.5% of the GDP (Gross Domestic Product).^[8] Health spending was 17.6% of the U.S. economy, reaching $4.87 trillion in 2023, and is expected to reach 19.7% by 2032.^[9] But with this phenomenal increase in spending, have we gotten better health?

read the rest at romanbystrianyk.substack.com